The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System

Monica A. Muñoz () and Gerald J. Dal Pan
Additional contact information
Monica A. Muñoz: US Food and Drug Administration
Gerald J. Dal Pan: US Food and Drug Administration

Drug Safety, 2019, vol. 42, issue 10, No 9, 1199-1201

Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-019-00834-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00834-1

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-019-00834-1

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().